HCA Sees FY24 EPS $21.60-$22.80, Up From $19.70-$21.20 vs $20.98 Est.
Portfolio Pulse from Bill Haddad
HCA Healthcare has raised its FY24 EPS guidance to $21.60-$22.80, up from the previous range of $19.70-$21.20, surpassing the consensus estimate of $20.98.
July 23, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HCA Healthcare has increased its FY24 EPS guidance to $21.60-$22.80, higher than the previous range and above the consensus estimate of $20.98. This positive revision indicates strong financial performance and could boost investor confidence.
The upward revision of EPS guidance suggests that HCA Healthcare is performing better than expected, which is likely to positively impact the stock price as it indicates strong financial health and growth prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100